IBEX (IBEX) earnings
IBEX earnings: last reported Thu, 10 Sep 2026, for the quarter ended Jun 2026.
IBEX earnings callsIBEX earnings calls (IBEX)
IBEX Q4 FY26 — Record Performance Driven by AI-Enabled Solutions and Strong Client Growth
What went well
- Record Q4 revenue of $164.3 million, up 12% YoY, marking the sixth consecutive quarter of double-digit growth.
- Full-year organic revenue growth of 15% to $644.1 million, with record adjusted EBITDA ($82.4M), EPS ($3.13), adjusted EPS ($3.52), operating cash flow ($59M), and free cash flow ($31.2M).
- Health Tech vertical grew 42% in Q4 to $29.4 million and 38% for the full year to $114 million, significantly surpassing the $100 million target.
What to watch
- Q4 GAAP net income decreased to $8.7 million from $9.6 million YoY, primarily due to training expenses for new client wins and temporary work transfer impacts.
- Q4 adjusted EBITDA decreased slightly to $20.2 million (12.3% of revenue) from $20.5 million (13.9% of revenue) YoY, impacted by new client expenses, work transfer, and higher fuel prices.
Performance +5.8% 1Y
1Y: $40.9 on 29 Sept 2025 → $43.26. High $44.53 (25 Sept 2026), low $26.4 (27 Mar 2026).
Quarterly results
Q2 FY26: revenue up 11.6%, net profit down 8.8% against the same quarter last year.
| Line item | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 130 | 141 | 141 | 147 | 151 +17% | 164 +17% | 164 +17% | 164 +12% |
| EBITDA | 9 | 12 | 13 | 12 | 14 +51% | 15 +28% | 16 +21% | 10 −20% |
| Net profit | 8 | 9 | 10 | 10 | 12 +60% | 12 +32% | 13 +27% | 9 −9% |
How to read this
US$ million, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Balance sheet
| Year ending | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|---|
| Equity capital | — | $2.0K | $2.0K | $2.0K | $1.0K | $2.0K |
| Reserves | — | -$76.36M | -$44.78M | -$11.12M | $25.74M | $72.07M |
| Total liabilities | — | $180.72M | $143.36M | $128.10M | $138.91M | $138.91M |
| Fixed assets | — | $41.94M | $41.15M | $29.86M | $32.56M | $40.73M |
| Total assets | — | $294.18M | $293.32M | $293.90M | $273.21M | $309.13M |
How to read this
As filed on each reporting date, including interim balance sheets. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Insider filings
96 filings between Oct 2, 2025 and Sep 25, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$6.42M
32 sales by 11 insiders
28% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 38
- Award — granted as compensation
- 1
- Option exercise — converted options into shares
- 23
- Tax withheld — shares kept back by the company to cover tax
Also filed: 2 other filings.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Dechant Robert Thomas | — | $2.61M | Sep 25, 2026 |
| Afdahl David Martin | — | $1.13M | Sep 14, 2026 |
| Casteel Julie K | — | $848.2K | Sep 15, 2026 |
| Dawson Bruce Neil | — | $615.4K | May 12, 2026 |
| Trofimuk-O'Connor Christina Alice | — | $435.3K | Sep 16, 2026 |
| Inson Paul Joseph | — | $310.6K | Sep 16, 2026 |
| Zhuang Mingzhe | — | $221.4K | Sep 15, 2026 |
| Greenwald Taylor C | — | $81.3K | May 22, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 25, 2026 | Dechant Robert Thomas Chief Executive Officer | Sale 10b5-1 plan | 5,000 | $225.1K |
| Sep 18, 2026 | Greenwald Taylor C Chief Financial Officer | Tax withheld | 3,293 | $132.4K |
| Sep 16, 2026 | Inson Paul Joseph Chief People Officer | Sale | 2,500 | $100.2K |
| Sep 16, 2026 | Trofimuk-O'Connor Christina Alice Chief Legal Officer | Sale | 2,376 | $93.5K |
| Sep 15, 2026 | Darwal Michael Joseph Chief AI & Digital Officer | Tax withheld | 270 | $10.9K |
| Sep 15, 2026 | Ballou-Aares Daniella Director | Sale | 1,500 | $60.4K |
| Sep 15, 2026 | Zhuang Mingzhe Director | Sale | 5,522 | $221.4K |
| Sep 15, 2026 | Casteel Julie K Chief Sales/Marketing Officer | Sale | 17,474 | $706.1K |
| Sep 15, 2026 | Dechant Robert Thomas Chief Executive Officer | Sale | 25,000 | $999.7K |
| Sep 15, 2026 | Trofimuk-O'Connor Christina Alice Chief Legal Officer | Sale | 7,500 | $302.3K |
| Sep 14, 2026 | Afdahl David Martin Chief Operating Officer | Sale 10b5-1 plan | 10,819 | $433.5K |
| Sep 14, 2026 | Inson Paul Joseph Chief People Officer | Sale 10b5-1 plan | 2,274 | $91.0K |
| Sep 8, 2026 | Afdahl David Martin Chief Operating Officer | Sale 10b5-1 plan | 17,500 | $649.0K |
| Jul 31, 2026 | Afdahl David Martin Chief Operating Officer | Tax withheld | 1,304 | $46.1K |
| Jul 31, 2026 | Trofimuk-O'Connor Christina Alice Chief Legal Officer | Award | 2,646 | $0 |
| Jul 31, 2026 | Afdahl David Martin Chief Operating Officer | Award | 2,646 | $0 |
| Jul 31, 2026 | Casteel Julie K Chief Sales/Marketing Officer | Tax withheld | 1,042 | $36.8K |
| Jul 31, 2026 | Beck Fiona Elizabeth Director | Award | 1,252 | $0 |
| Jul 31, 2026 | Greenwald Taylor C Chief Financial Officer | Award | 3,307 | $0 |
| Jul 31, 2026 | Casteel Julie K Chief Sales/Marketing Officer | Award | 2,646 | $0 |
| Jul 31, 2026 | Dechant Robert Thomas Chief Executive Officer | Tax withheld | 4,910 | $173.5K |
| Jul 31, 2026 | Dechant Robert Thomas Chief Executive Officer | Award | 10,826 | $0 |
| Jul 31, 2026 | Dawson Bruce Neil Chief Sales and CS Officer | Tax withheld | 855 | $30.2K |
| Jul 31, 2026 | Dawson Bruce Neil Chief Sales and CS Officer | Award | 1,954 | $0 |
| Jul 31, 2026 | Jones John William Director | Award | 1,353 | $0 |
| Jul 31, 2026 | Batungbacal Karen Director | Award | 1,252 | $0 |
| Jul 31, 2026 | Zhuang Mingzhe Director | Award | 1,252 | $0 |
| Jul 31, 2026 | Ballou-Aares Daniella Director | Award | 1,252 | $0 |
| Jul 31, 2026 | McGinnis Patrick Director | Award | 1,252 | $0 |
| Jul 31, 2026 | Inson Paul Joseph Chief People Officer | Tax withheld | 1,053 | $37.2K |
| Jul 31, 2026 | Trofimuk-O'Connor Christina Alice Chief Legal Officer | Tax withheld | 950 | $33.6K |
| Jul 31, 2026 | Inson Paul Joseph Chief People Officer | Award | 2,405 | $0 |
| Jul 31, 2026 | Greenwald Taylor C Chief Financial Officer | Tax withheld | 956 | $33.8K |
| Jul 20, 2026 | Darwal Michael Joseph Chief AI & Digital Officer | Other | 200 | $7.0K |
| Jul 1, 2026 | Afdahl David Martin Chief Operating Officer | Tax withheld | 1,138 | $36.0K |
| Jul 1, 2026 | Darwal Michael Joseph Chief AI & Digital Officer | Tax withheld | 316 | $10.0K |
| Jul 1, 2026 | Inson Paul Joseph Chief People Officer | Tax withheld | 823 | $26.0K |
| Jul 1, 2026 | Dechant Robert Thomas Chief Executive Officer | Tax withheld | 4,511 | $142.5K |
| Jul 1, 2026 | Casteel Julie K Chief Sales/Marketing Officer | Tax withheld | 910 | $28.8K |
| Jul 1, 2026 | Dawson Bruce Neil Chief Sales and CS Officer | Tax withheld | 886 | $28.0K |
| Jul 1, 2026 | Trofimuk-O'Connor Christina Alice Chief Legal Officer | Tax withheld | 700 | $22.1K |
| Jul 1, 2026 | Greenwald Taylor C Chief Financial Officer | Tax withheld | 853 | $27.0K |
| Jun 11, 2026 | Casteel Julie K Chief Sales/Marketing Officer | Sale | 3,600 | $110.2K |
| May 28, 2026 | McGinnis Patrick Director | Sale | 1,030 | $32.6K |
| May 22, 2026 | Greenwald Taylor C Chief Financial Officer | Award | 3,333 | $0 |
| May 22, 2026 | Greenwald Taylor C Chief Financial Officer | Sale | 964 | $30.9K |
| May 13, 2026 | Dechant Robert Thomas Chief Executive Officer | Sale | 7,800 | $237.9K |
| May 12, 2026 | Dawson Bruce Neil Chief Sales and CS Officer | Sale | 15,260 | $474.8K |
| May 11, 2026 | Dawson Bruce Neil Chief Sales and CS Officer | Sale | 3,129 | $102.6K |
| Mar 2, 2026 | Batungbacal Karen Director | Award | 2,083 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.